Biobery Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
About Biobery Lifesciences
Biobery Lifesciences Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 January 2020 (Five years and one month 1 days old ). Its registered office is in Agra, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Jyoti Prasad, Saurabh Sawhney, Alok Kashyap, and Three other members serve as directors at the Company.
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304UP2020PTC125945
- Company No.
125945
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2020
- Date of AGM
04 Aug 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Biobery Lifesciences?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Prasad  | Director | 21-Jan-2020 | Current |
| Saurabh Sawhney | Director | 21-Jan-2020 | Current |
| Alok Kashyap | Director | 21-Jan-2020 | Current |
| Devendra Upadhyay | Director | 21-Jan-2020 | Current |
| Narayan Tiwari | Director | 21-Jan-2020 | Current |
| Shri Sharma | Director | 08-Jul-2020 | Current |
Financial Performance of Biobery Lifesciences.
Biobery Lifesciences Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Biobery Lifesciences?
Unlock access to Biobery Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ogiso Life Sciences Private LimitedJyoti Prasad and Saurabh Sawhney are mutual person
Zyrath Health Care Private LimitedJyoti Prasad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biobery Lifesciences?
Unlock and access historical data on people associated with Biobery Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biobery Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biobery Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.